HeartBeam, Inc. (BEAT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US42238H1086
HeartBeam, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -21.14 m USD |
| EBIT | -21.02 m USD |
| Net income | -21.02 m USD |
| Diluted EPS – continuing operations | -0.62 USD |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About HeartBeam, Inc.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
More stocks
- Zivo Bioscience, Inc. (ZIVO)
- Aeries Technology, Inc. (AERT)
- Beachbody Company, Inc. (BODI)
- BIOLARGO, INC. (BLGO)
- LIVE VENTURES Inc (LIVE)
- Transcode Therapeutics, Inc. (RNAZ)
- Retrieve Medical Holdings, Inc. (RMHI)
- FRANKLIN WIRELESS CORP (FKWL)
- Stark Novus Financial Inc. (SNFI)
- AMERICAN VANGUARD CORP (AVD)
- CREDITRISKMONITOR COM INC (CRMZ)
- BetterLife Pharma Inc. (BETRF)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.